Riskpilot← Back to searchSign inGet full accessRahm Hälsa & Sjukvård AB
ABActiveOrg 5590425400Fridhemsplan 2 B BvPhysiotherapy activities · NACE 8695Est. 20151 employees
Revenue 2025
SEK 1M
0% vs 2024
EBITDA margin
3.8%
-80% vs 2024
Equity ratio
44.7%
Financial strength
Net profit 2025
SEK 5K
-96% vs 2024
| Revenue | SEK 1M | +0% |
| EBITDA | SEK 38K | -80% |
| Net profit | SEK 5K | -96% |
| Total assets | SEK 1,2M | +9% |
| Equity | SEK 544K | +1% |
| Employees | 1 | — |
Legal name
Rahm Hälsa & Sjukvård AB
Org number
5590425400
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
17 december 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva hälso- och sjukvård främst med naprapati och träning, kursverksamhet och utbildning, försäljning av hälsoprodukter och ergonomiska hjälpmedel samt därmed förenlig verksamhet.
Address
Fridhemsplan 2 B Bv
Email
info@andersrahm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 192 | 738 | 975 | 1 019 | 1 019 |
| Staff expenses | — | −488 | −585 | −608 | −722 |
| EBITDA | 232 | 17 | 210 | 195 | 38 |
| Depreciation & amort. | −0 | — | — | — | −1 |
| EBIT | 232 | 17 | 210 | 195 | 38 |
| Net financials | −4 | −20 | −24 | −33 | −28 |
| Profit before tax | 229 | −3 | 187 | 161 | 9 |
| Tax | −50 | −1 | −39 | −34 | −4 |
| Net profit | 179 | −3 | 148 | 127 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 081 | 990 | 1 057 | 1 119 | 1 216 |
| Equity | 342 | 289 | 412 | 539 | 544 |
| Long-term debt | 629 | 558 | 488 | 417 | 483 |
| Short-term debt | 110 | 143 | 158 | 163 | 189 |
| Total debt | 739 | 701 | 646 | 580 | 672 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20212025
Equity ratio
44.7%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20212025
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
20212025
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2024 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rahm Hälsa & Sjukvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mica Caroline Rahm | Board of Directors | 0 companies |
| Sven Erik Bengtsson | Deputy Board Member | 0 companies |
| Mikko Pekka Talala | Board of Directors | 0 companies |
| Lars Anders Rahm | Chairman | 0 companies |